Medical Marijuana is Expected to Impact the Healthcare Market

 

https://www.biospace.com/article/releases/medical-marijuana-is-expected-to-impact-the-healthcare-market/

Note:  Cannabis for medical purposes is garnering acceptance globally, here are some companies to keep an eye on as the market grows. According to a new report published by Zion Market Research, the global medical cannabis market was valued at USD 11.8 Billion in 2017 and expected to reach 40.9 Billion by the end of 2024. The market is also projected to register a compound annual growth rate (CAGR) of 19.4% during the forecast period. Medical cannabis has the potential to make an impact on the healthcare market as continued efforts have been focused on the possibility of cannabis use as a treatment option for numerous medical conditions, include chronic pain, peripheral neuropathic pain and others. In addition, the legalization of medical cannabis in emerging countries is projected to boost the demand for medical cannabis. CLS Holdings, USA Inc. (OTC: CLSH), Tilray, Inc. (NASDAQ: TLRY), Innovative Industrial Properties, Inc. (NYSE: IIPR), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Pyxus International, Inc. (NYSE: PYX)

This article profiles these major cannabis companies.

Leave a Reply

Your email address will not be published.